Intended for healthcare professionals

Archive

Fluvoxamine shows efficacy in long-COVID fatigue

Written by | 31 Mar 2026

Researchers report that the antidepressant fluvoxamine has significantly reduced long COVID–related fatigue, and that the diabetes drug metformin has no such benefit. “Patients taking fluvoxamine reported steadily improving […]

Trial finds vitamin D supplements don’t reduce covid severity but could reduce long COVID risk

Written by | 17 Mar 2026

Mass General Brigham study results signal a call to do further research into the connection between vitamin D supplementation and long COVID In a large, randomized trial, researchers […]

POTS common in patients with long COVID

Written by | 8 Oct 2025

A new study from Karolinska Institutet in Sweden shows that an unusual heart rhythm disorder, POTS, is particularly common in people with long COVID. The majority of those […]

New study shows obesity linked to long COVID

Written by | 27 May 2025

New research by Edith Cowan University (ECU) Centre of Precision Health visiting PhD scholar Ms Debora Barbosa Ronca found that people with excess weight are more likely to […]

Children face elevated kidney, heart, and gut risks for years after COVID infection

Written by | 1 May 2025

Long COVID can result in increased risk for a variety of serious health problems for young people, including those affecting the kidney, gut, and cardiovascular system, according to […]

Pain identified as dominant symptom in long Covid

Written by | 31 Aug 2024

Pain may be the most prevalent and severe symptom reported by individuals with long Covid, according to a new study led by UCL (University College London) researchers. The study, […]

Nearly one in 10 pregnant people who get COVID will develop long COVID

Written by | 16 Jul 2024

Nearly one in 10 people who get COVID while pregnant will go on to develop long COVID, a report publishing July 11th in Obstetrics & Gynecology has found. “It was surprising to […]

How long COVID survivors are revolutionizing health care

Written by | 29 Mar 2024

To the world’s public health authorities, Covid-19 would be either a deadly disease for some or a simple respiratory illness for most, its symptoms clearing up in just […]

Study finds paxlovid treatment does not reduce risk of long COVID

Written by | 7 Jan 2024

A team of researchers from UC San Francisco has found that Paxlovid (Nirmatrelvir-ritonavir) did not reduce the risk of developing long COVID for vaccinated, non-hospitalized individuals during their […]

Vaccination before Covid-19 infection significantly reduces risk of long covid

Written by | 25 Nov 2023

Covid-19 vaccination prior to infection significantly reduces the risk of developing post-covid-condition (PCC), commonly known as long covid, researchers reported on Nov. 22, 2023 in The BMJ/British Medical […]

Raising awareness of Long Covid ‘blue legs’ symptom

Written by | 16 Aug 2023

An unusual case of a Long Covid patient’s legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom among people with […]

Long COVID not caused by COVID-19 immune inflammatory response, new research finds

Written by | 17 Jul 2023

Long Covid, which affects nearly two-million people in the UK1, is not caused by an immune inflammatory reaction to COVID-19, University of Bristol-led research finds.  Emerging data demonstrates that […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.